Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FSKF2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,783
Award facts
- Contract value 100% obligated
- $4,783.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a firm fixed-price delivery order valued at $4,783.32 to DMS Pharmaceutical Group Inc. for 52 mg Mirena systems, contraceptive devices used across the Department of Defense medical supply chain. The award, issued on December 17, 2025, with completion targeted for January 9, 2026, represents a routine pharmaceutical procurement executed without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, is a critical supplier within the federal pharmaceutical distribution network, demonstrating competitive capability to win unrestricted federal procurement opportunities.
This delivery order is issued under DMS Pharmaceutical Group's broader Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) indefinite delivery contract with the Defense Logistics Agency, awarded November 13, 2025, with a $499.999 billion ceiling and completion date of December 31, 2036. The PPV-G GEN V represents a comprehensive $30.3 billion acquisition strategy establishing multiple regional prime vendor contractors to supply branded and generic pharmaceuticals, biologics, and medical consumables to support Department of Defense healthcare operations globally. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the specialized pharmaceutical requirements of the federal military medical system.
Quick answers
Who was awarded contract SPE2DR26FSKF2?
SPE2DR26FSKF2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FSKF2 worth?
The government has obligated $4,783 on SPE2DR26FSKF2.
Is contract SPE2DR26FSKF2 an order under another contract?
Yes. SPE2DR26FSKF2 is a delivery order under SPE2DR25D9317, an indefinite delivery contract.
Was contract SPE2DR26FSKF2 competed?
The extent of competition for SPE2DR26FSKF2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award